riccardin-d and Neoplasms

riccardin-d has been researched along with Neoplasms* in 1 studies

1 other study(ies) available for riccardin-d and Neoplasms

Article	Year
Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance. Signal transduction and targeted therapy, 2021, 06-07, Volume: 6, Issue:1 Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Neoplasms; PC-3 Cells; Phenyl Ethers; Stilbenes; Vesicular Transport Proteins	2021